ISRCTN52543592
Completed
Not Applicable
A multicenter randomised study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma
eyenburg Hospital (The Netherlands) - Department of Hematology0 sites195 target enrollmentDecember 20, 2005
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Platelet transfusion
- Sponsor
- eyenburg Hospital (The Netherlands) - Department of Hematology
- Enrollment
- 195
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients greater than 18 years expected to receive platelet transfusions.
Exclusion Criteria
- •HLA\- and/or HPA allo\-immunisation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Randomized multicenter study to compare survival and clinical improvement of methicillin resistant Staphylococcus aureus bacteremia in hospitalized patients when they are treated with combination of Daptomycin plus Fosfomycin versus Daptomycin alone.EUCTR2013-000586-37-ESMiquel Pujol Rojo (Infectious Diseases Service-Hospital Universitari de Bellvitge-IDIBELL)
Recruiting
Not Applicable
A multicenter prospective study of the efficacy of prophylactic clip closure for prevention of delayed bleeding after colorectal ESD (endoscopic submucosal dissection)Colorectal neoplasmsJPRN-UMIN000036734Osaka University Graduate School of Medicine45
Recruiting
Not Applicable
A prospective multicenter study of the efficacy of pranlukast hydrate for infant patients with acute wheezing illness caused by RS virus infectioRepsratory Syncytial virus: RSVJPRN-UMIN000025608agoya University Hospital160
Recruiting
Phase 2
A Clinical Trial to study the effects of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral ConjunctivitisCTRI/2012/11/003145ovaBay Pharmaceutical Inc440
Completed
Not Applicable
A Clinical Trial to study the effects of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral ConjunctivitisAdenoviral ConjunctivitisSLCTR/2013/026ovaBay Pharmaceutical, Inc